Progression Free Survival by the Treatment With Cabozatinib in a Case of BRAF Mutated Radioiodine Refractory Recurrent Metastatic Papillary Carcinoma Thyroid. Bangladesh J of Otorhinolaryngology 2026, 31 (2), 86-94. https://doi.org/10.3329/bjo.v31i2.89000.